Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics?

D’Antongiovanni, V., Pellegrini, C., Fornai, M., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2023). Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics? Journal of Drug Targeting, 31(7), 693–699. https://doi.org/10.1080/1061186x.2023.2235092
Authors:
Vanessa D'Antongiovanni
Carolina Pellegrini
Matteo Fornai
Zoltan H Nemeth
György Haskó
Luca Antonioli
Affiliated Authors:
Zoltan H Nemeth
György Haskó
Columbia Affiliation:
Subjects:
Inflammatory Bowel Diseases (MeSH)
Colitis, Ulcerative (MeSH)
Crohn Disease (MeSH)
Author Keywords:
chron disease
ibd
p2x4 receptor
gut dysmotility
immune system
inflammatory bowel disease
intestinal inflammation
ulcerative colitis
visceral pain
elink
Publication Type:
Article
Unique ID:
10.1080/1061186x.2023.2235092
PMID:
37474908
DOI:
10.1080/1061186x.2023.2235092
Journal:
Journal of Drug Targeting
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: